We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Comparison of clinical outcomes of pulmonary nocardiosis between AIDS and non-AIDS patients

    Background

    Nocardia species can affect both immunocompetent and immunocompromised people.

    Method

    This retrospective study, from 2009 to 2022, aims to...

    Wilawan Thipmontree, Yupin Suputtamonkol in BMC Infectious Diseases
    Article Open access 28 June 2024
  2. Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

    Introduction

    Recurrent Clostridioides difficile infection (rCDI) often occurs after standard-of-care antibiotics. VOWST oral spores (VOS, previously...

    Colleen S. Kraft, Matthew Sims, ... Shari E. Rozen in Infectious Diseases and Therapy
    Article Open access 28 June 2024
  3. Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring

    Background

    Intravenous fosfomycin (IVFOF) is gaining interest in severe infections. Its use may be limited by adverse events (AEs). Little experience...

    Simona Biscarini, Davide Mangioni, ... Alessandra Bandera in BMC Infectious Diseases
    Article Open access 28 June 2024
  4. Was kann die Pneumologie von der Thoraxchirurgie erwarten?

    In recent years thoracic surgery and pneumology have made impressive advances in their diagnostic and therapeutic options. In the surgical treatment...

    Laura V. Klotz, Katrin Welcker in Zeitschrift für Pneumologie
    Article 28 June 2024
  5. Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study

    Background

    Observational studies have found a link between two autoimmune diseases, namely, primary sclerosing cholangitis (PSC) and systemic lupus...

    Ziwen Pan, Weijie Zhang in European Journal of Medical Research
    Article Open access 28 June 2024
  6. Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19

    Introduction

    This study aimed to evaluate the effectiveness of ensitrelvir, an oral antiviral, in reducing hospitalization risk in outpatients at...

    Takahiro Takazono, Satoki Fujita, ... Hiroshi Mukae in Infectious Diseases and Therapy
    Article Open access 28 June 2024
  7. Akut-auf-chronisches Leberversagen

    Tony Bruns, Christian Lange in Die Gastroenterologie
    Article 28 June 2024
  8. Seasonal distribution and upsurge of respiratory viruses among indigenous tribes with ILI and SARI in a far-flung Car Nicobar Island

    Background

    Respiratory viral illnesses among children are a prominent cause of morbidity and mortality in the develo** world. The aim of this study...

    Nagarajan Muruganandam, Veena Vipat, ... Varsha Potdar in BMC Infectious Diseases
    Article Open access 28 June 2024
  9. Azithromycin sequential therapy plus inhaled terbutaline for Mycoplasma Pneumoniae pneumonia in children: a systematic review and meta-analysis

    Background

    An improper host immune response to Mycoplasma pneumoniae generates excessive inflammation, which leads to the impairment of pulmonary...

    Yongcheng Sheng, Yi Liang, ... Xueting Liu in BMC Infectious Diseases
    Article Open access 28 June 2024
  10. Duration of effectiveness of the COVID-19 vaccine in Japan: a retrospective cohort study using large-scale population-based registry data

    Background

    Most evidence of the waning of vaccine effectiveness is limited to a relatively short period after vaccination.

    Methods

    Data obtained from...

    Kohei Uemura, Sachiko Ono, ... Hideo Yasunaga in BMC Infectious Diseases
    Article Open access 28 June 2024
  11. Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis

    Background

    Human T-cell lymphotropic virus type 1 (HTLV-1), also denominated Human T-cell leukemia virus-1, induces immune activation and secretion of...

    Luana Leandro Gois, Bárbara Ribeiro-Soares, ... Maria Fernanda Rios Grassi in BMC Infectious Diseases
    Article Open access 28 June 2024
  12. An overview of fasciolosis in Nepal: epidemiology, diagnosis, and control strategies

    Fasciolosis, caused by Fasciola hepatica and Fasciola gigantica , is a globally prevalent vector-borne disease that affects livestock and humans, with...

    Article 28 June 2024
  13. Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment

    Cancer, a prevalent and complex disease, presents a significant challenge to the medical community. It is characterized by irregular cell...

    Haihong Lin, Jun Zhou, ... **aoling Wang in European Journal of Medical Research
    Article Open access 28 June 2024
  14. Geographical and temporal dynamics of genetic diversity of Plasmodium falciparum merozoite surface proteins 1/2 in India

    The high genetic diversity of Plasmodium falciparum ( Pf ) is a big obstacle to successful vaccine development programs. Here, the geographical and...

    Loick Pradel Kojom Foko, Jahnvi Jakhan, ... Vineeta Singh in Journal of Parasitic Diseases
    Article 28 June 2024
Did you find what you were looking for? Share feedback.